title: In vivo behavior of bioactive phosphate glass-ceramics from the system P2O5-Na2O-CaO containing TiO2.
abstract: Soda lime phosphate bioglass-ceramics with incorporation of small additions of TiO2 were prepared in the metaphosphate and pyrophosphate region, using an appropriate two-step heat treatment of controlled crystallization defined by differential thermal analysis results. Identification and quantification of crystalline phases precipitated from the soda lime phosphate glasses were performed using X-ray diffraction analysis. Calcium pyrophosphate (beta-Ca2P2O7), sodium metaphosphate (NaPO3), calcium metaphosphate (beta-Ca(PO3)2), sodium pyrophosphate (Na4P2O7), sodium calcium phosphate (Na4Ca(PO3)6) and sodium titanium phosphate (Na5Ti(PO4)3) phases were detected in the prepared glass-ceramics. The degradation of the prepared glass-ceramics were carried out for different periods of time in simulated body fluid at 37 degrees C using granules in the range of (0.300-0.600 mm). The released ions were estimated by atomic absorption spectroscopy and the surface textures were measured by scanning electron microscopy. Evaluation of in vivo bioactivity of the prepared glass-ceramics was carried through implanting the samples in the rabbit femurs. The results showed that the addition of 0.5 TiO2 mol% enhanced the bioactivity while further increase of the TiO2 content decreased the bioactivity. The effect of titanium dioxide on the bioactivity was interpreted on the basis of its action on the crystallization process of the glass-ceramics.
authors: Biophysics Department, Faculty of Science, Cairo University, Cairo, Egypt.
authors: Ahmed Soltan
authors: AS
authors: Monem
authors: Hatem A
authors: HA
authors: ElBatal
authors: Elsayed M A
authors: EM
authors: Khalil
authors: Moenis A
authors: MA
authors: Azooz
authors: Yousry M
authors: YM
authors: Hamdy
mesh_terms: D000818:Animals; D002516:Ceramics / Q000737:chemistry / Q000494:pharmacology*; D003343:Corrosion; D004055:Differential Thermal Analysis; D005269:Femur / Q000187:drug effects / Q000502:physiology; D005898:Glass / Q000737:chemistry*; D008297:Male; D008855:Microscopy, Electron, Scanning; D016348:Osseointegration / Q000187:drug effects; D011817:Rabbits; D014025:Titanium / Q000737:chemistry* / Q000494:pharmacology*; D014961:X-Ray Diffraction
chemical_list: C022107:Bioglass; C118163:sodium oxide-calcium oxide-diphosphorus pentoxide glass; C009495:titanium dioxide; C023506:Glass ceramics; D014025:Titanium
references: J Biomed Mater Res. 1992 Feb;26(2):255-67
references: 1569117
references: J Biomed Mater Res. 1990 Jun;24(6):721-34
references: 2361964
references: J Biomed Mater Res. 1991 Oct;25(10):1303-15
references: 1812121
references: Biomaterials. 1995 Sep;16(14):1101-7
references: 8519932
references: Biomaterials. 2001 Mar;22(5):497-501
references: 11214761
references: Dent Mater. 1991 Apr;7(2):124-9
references: 1936640
references: J Mater Sci Mater Med. 2000 Oct;11(10):615-20
references: 15348085
references: Biomaterials. 1993 Feb;14 (3):216-24
references: 8386554
references: Biomaterials. 1999 Aug;20(15):1415-20
references: 10454013
references: Biomaterials. 1997 Jul;18(13):915-21
references: 9199761
references: J Control Release. 2004 Apr 16;96(1):29-36
references: 15063027
references: Biomaterials. 1999 Sep;20(18):1727-41
references: 10503974